Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand. New sites opening in US and UK to realize regional manufacturing models. Overall, the companies plan to hire 2000 full-time associates over the next two years. Investment follows five strategic acquisitions made by [...]

AMSBIO has launched a new range of research grade biosimilars that enable analysis of biological processes without the need to purchase expensive therapeutic-grade biologics. Investigating the biological effects of a drug or doing proof of concept assay development, requires a source of the drug. Typically, it is difficult to obtain original pharmaceutical grade biotherapeutic drugs for research use, [...]

Strengthening Bio-Techne's leadership in the spatial genomics market with significant expansion of the ACD RNAscope HiPlex platform capabilities MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope in situ hybridization technology portfolio with the release of new RNAscope HiPlex V2 assay for formalin-fixed paraffin-embedded (FFPE) [...]

Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes  PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). The agreement resolves all outstanding litigation and other proceedings between the two companies across [...]

Accelerated efforts align with the Paris Agreement and Race To Zero to combat climate change WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced its commitment to achieve net-zero carbon emissions by 2050. This supports the global goals of the Paris Climate Agreement and the United Nations' [...]

Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models Dublin, Ireland & Shizuoka, Japan: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and Japan SLC, Inc., a biotechnology company providing animal models to the research community, today [...]

HOUSTON--(BUSINESS WIRE)--Jul. 26, 2021-- Kiromic Biopharma, Inc. (Nasdaq: KRBP), a pioneer in immuno oncology cellular therapy in solid tumors, is pleased to announce it has completed the acquisition of InSilico Solutions. InSilico Solutions is a world-class bio-informatics and artificial intelligence innovator with a long standing collaborative relationship with its clients at MD Anderson Cancer Center, Johns Hopkins School of [...]

Porvair Sciences reports on the installation of new automated precision die-cutting equipment that has enabled a five-fold increase in its production capacity for porous plastic components. This major investment by the company is in response to a significant rise in demand from customers for precision components made from its high performance Vyon® porous plastics. Installed [...]

TOKYO – PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President & CEO: John Marotta, hereafter PHCHD), a leading global healthcare company, has today announced the appointment of Alan Malus and Kyoko (Kay) Deguchi as independent external directors, effective June 30, 2021. Both bring extensive knowledge of the healthcare industry and executive-level experience at international and [...]

Scintica is excited to announce its new and extended distribution agreement with Baker Ruskinn, global leader and supplier of anaerobic and modified atmosphere solutions for microbiology and tissue/cell culture applications. The Baker Company, global leader in containment technology, owner of Baker Ruskinn, itself a global leader in anaerobic and precision low-oxygen culture solutions for microbiology [...]